Finance

Lists
6869:TYO
Sysmex Corp
Â¥2,128.00
-1.46%
(-31.50) 1D
Nov 20, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6869...
Open
Â¥2,110
High
Â¥2,155
Low
Â¥2,100
Mkt. cap
1.29T
Avg. vol.
3.42M
Volume
1.93M
Dividend
1.79%
Quarterly dividend
Â¥10
Ex-dividend date
Mar 30, 2027
P/E ratio
38.09
52-wk high
Â¥2,228
52-wk low
Â¥1,246
EPS
Â¥56
Shares outstanding
208.64M
No. of employees
11K
Open
Â¥2,110
High
Â¥2,155
Low
Â¥2,100
Mkt. cap
1.29T
Avg. vol.
3.42M
Volume
1.93M
Dividend
1.79%
Quarterly dividend
Â¥10
Ex-dividend date
Mar 30, 2027
P/E ratio
38.09
52-wk high
Â¥2,228
52-wk low
Â¥1,246
EPS
Â¥56
Shares outstanding
208.64M
No. of employees
11K
News stories
From web sources and news partners
Profile
Sysmex Corporation is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers. The company was renamed Sysmex Corporation in 1998 taking advantage of brand recognition of their machines. Wikipedia
About Sysmex Corp
CEOHisashi Ietsugu
Employees10.9K
FoundedFeb 20, 1968
HeadquartersKobe, Hyogo, Japan
SectorHealth Care
IndustryMedical device
Last report
Nov 11, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
142.15B / 135.39B
+4.99%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
133.74B
138.84B
136.41B
142.15B
Cost of goods sold
67.18B
70.79B
66.19B
68.02B
Cost of revenue
67.18B
70.79B
66.19B
68.02B
Research and development expenses
7.98B
-20.44B
7.11B
7.02B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.24B
73.31B
42.74B
42.86B
Operating expense
51.35B
53.20B
50.62B
49.75B
Total operating expenses
118.52B
123.99B
116.81B
117.77B
Operating income
15.22B
14.85B
19.60B
24.38B
Other non operating income
1.50M
-640.00M
-2.00M
-3.00M
EBT including unusual items
9.55B
1.58B
14.57B
15.03B
EBT excluding unusual items
15.33B
14.70B
17.45B
20.80B
Income tax expense
1.29B
-272.00M
5.66B
5.82B
Effective tax rate
13.53%
-17.22%
38.85%
38.76%
Other operating expenses
129.00M
337.00M
766.50M
-131.00M
Net income
8.22B
1.76B
8.97B
9.24B
Net profit margin
6.15%
1.27%
6.57%
6.50%
Earnings per share
-
-
-
-
Interest and investment income
212.00M
541.00M
242.50M
240.00M
Interest expense
-1.27B
-
-1.35B
-1.44B
Net interest expenses
-1.06B
541.00M
-1.11B
-1.20B
Depreciation and amortization charges
-
-
-
-
EBITDA
27.02B
26.47B
31.50B
36.16B
Gain or loss from assets sale
313.50M
11.72B
221.00M
6.06B
Upcoming events
AI content may include mistakes. Learn more
Google apps